# The word survivor, and why the vocabulary is not a detail

Source: https://onco.cc/technologies/rejuv-mind-the-word-survivor/  
OnCo record `rejuv-mind-the-word-survivor` (Technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

In the one in-depth British study to ask, most of 40 people interviewed at least five years after a diagnosis of breast, bowel or prostate cancer rejected the word survivor, and the authors recommended descriptive terms instead. A wider review of eight cancer studies found the opposite in five of them, which is the point: there is no single right word.

## Summary

The British qualitative study interviewed 40 people at least five years past a diagnosis of breast, colorectal or prostate cancer and asked each whether they felt they were a cancer survivor. "The majority of respondents did not endorse the term 'cancer survivor', and there was a wide variation in its interpretation." Those who accepted it took it as a plain factual description: they had had cancer and were alive. The reasons given for rejecting it are specific and worth reading as reasons rather than preferences. It implied a high risk of death that did not reflect their experience. It suggested that surviving cancer depended on personal characteristics, which is to say on being the kind of person who survives. It implied being cured, when recurrence remained possible. And it was a label that did not describe their identity, or that implied an advocacy role they did not want. The authors concluded that "Researchers and policy makers in the UK should consider avoiding the term 'cancer survivor' in favour of descriptive terms when discussing this population."

That is not the whole literature. A scoping review of terminology preferences across healthcare settings identified 41 primary studies, of which eight focused on cancer survivorship: five found a preference for "survivor" and three for "someone who had had cancer". The review's main finding across the other 33 studies was that people accessing healthcare generally prefer "patient" to "client" or "consumer".

So the evidence supports a weaker and more useful claim than either side usually makes: a meaningful minority, and in the one British in-depth study a majority, actively dislike the standard word, and the reasons they give are about the implied moral content. The word carries, for some people, the suggestion that staying alive was an achievement and therefore that dying would have been a failure. That implication is the same one the tone rules on this site exist to remove from survival statistics, and it is the reason this is not a matter of taste.

What the alternatives are, with their own problems. "Patient" is accurate during treatment and strange years afterwards. "Survivor" is the standard term in research and in American practice, where it conventionally covers the whole period from diagnosis onward, which is itself a source of confusion when a reader meets it. "Someone who has had cancer" is accurate and clumsy. "Living with and beyond cancer" is the phrasing several British charities and services use and is the one that covers people whose cancer has not gone. "Ex-patient", "cured" and "in remission" each make a claim about disease status that may not be true. None of them is right for everybody, which is why the recommendation from the British study is descriptive language rather than a replacement label.

Why this belongs in a knowledge graph rather than a style guide. Vocabulary determines what is findable. The research literature indexes this material under survivorship, so a reader looking for late effects, follow-up or psychological support has to use a word many of them reject in order to find anything. The practical advice is therefore the opposite of avoidance: the word is worth knowing as a search term even if it is not worth using about yourself. In its own writing OnCo prefers the descriptive form, says "after treatment" or "people who have had cancer" where that reads naturally, and keeps "survivorship" where it is the name of a field, a guideline or a service.

## Fields

- Kind: Technology
- Status: established
- Last checked: 2026-10-02
- Tags: rejuvenation; survivorship; psychosocial
- Principle: A label applied by a system to a group becomes an identity claim about each member of it. Where the label implies that the outcome was earned, as "survivor" does for some of the people asked, it attaches a moral reading to a biological event, and the same mechanism makes "lost their battle" unacceptable at the other end. The research use of the term is a classification; the personal use of it is a claim, and the two do not have to match.
- Strengths: An in-depth British study that asked rather than assumed, with the reasons recorded; A wider review showing the opposite preference elsewhere, so the finding is not overstated; The alternatives and their drawbacks are known, which makes a considered choice possible
- Limitations: The British study interviewed 40 people and is qualitative; Preference varies by country, by cancer and by how long ago treatment ended; The research literature is indexed under the word many people reject, so avoiding it has a cost

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Cancer_survivor
- Interpretation and acceptance of the term 'cancer survivor': a United Kingdom-based qualitative study (Eur J Cancer Care 2012): https://doi.org/10.1111/j.1365-2354.2011.01277.x
- Patient, client, consumer, survivor or other alternatives? A scoping review of preferred terms for labelling individuals who access healthcare across settings (BMJ Open 2020): https://doi.org/10.1136/bmjopen-2018-025166
- Categorization of cancer survivors: why we need it (JCO 2016): https://doi.org/10.1200/JCO.2016.68.3870

## Connected records

- ideas: [Paid survivor peer-navigators as a recognised health workforce role](https://onco.cc/ideas/idea-moon-peer-navigator-workforce/)
- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- fronts: [Recovery & Rejuvenation](https://onco.cc/fronts/rejuvenation/), [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- technologies: [Body image after cancer treatment: how it is measured, what drives it, and what helps](https://onco.cc/technologies/rejuv-mind-body-image-after-cancer/), [Post-traumatic growth: what people report, and what the measurement actually captures](https://onco.cc/technologies/rejuv-mind-post-traumatic-growth/), [Psycho-oncology and distress screening](https://onco.cc/technologies/psycho-oncology/), [Survivorship care and late-effects surveillance](https://onco.cc/technologies/survivorship-care-plan/)
- terms: [Late effects and survivorship toxicity](https://onco.cc/terms/late-effects/), [Quality of life](https://onco.cc/terms/quality-of-life/), [Seasons of Survival: the 1985 essay that named the problem](https://onco.cc/terms/rejuv-history-seasons-of-survival/), [The founding of the National Coalition for Cancer Survivorship, and the word survivor](https://onco.cc/terms/rejuv-history-survivorship-movement/)
- bottlenecks: [Survivorship and late effects are neglected](https://onco.cc/bottlenecks/b-survivorship/)
- roadmaps: [Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it](https://onco.cc/roadmaps/rejuvenation-roadmap/)
- people: [Fitzhugh Mullan](https://onco.cc/people/fitzhugh-mullan/)

---
JSON: https://onco.cc/api/v1/entities/rejuv-mind-the-word-survivor.json